Dr. Ajit Pal Singh Sandhu, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 680 Mowry Ave, Fremont, CA 94536 Phone: 510-790-1511 Fax: 510-791-8820 |
Dr. Marco Pavesi, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2557 Mowry Ave, Suite 12, Fremont, CA 94538 Phone: 510-793-3722 Fax: 510-793-8783 |
Dr. Jason Chu, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2557 Mowry Ave, Suite 12, Fremont, CA 94538 Phone: 510-793-3722 Fax: 510-793-8783 |
News Archive
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for AvodartĀ® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.
Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO.
All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.
› Verified 9 days ago